Physical Therapy in Cardiovascular and Pulmonary Conditions



Physical Therapy in Cardiovascular and Pulmonary Conditions


Tiffany Hilton






General Description


Prevalence


Physical therapists (PTs) and physical therapist assistants (PTAs) promote heath and wellness and the prevention and management of cardiovascular and pulmonary conditions. Regardless of the clinical setting, PTs and PTAs may treat patients with cardiac and pulmonary conditions as primary or secondary diagnoses. Significant advances in the diagnosis and treatment of cardiovascular and pulmonary conditions during the past 30 years, coupled with positive changes in modifiable risk factors, have resulted in a decline in the number of deaths. As individuals with these conditions are living longer lives, PTs and PTAs play a major role in improving functional performance, enhancing quality of life, and increasing the chances of living an independent life after disease. Despite the remarkable progress, cardiovascular and pulmonary conditions remain leading causes of morbidity and mortality.


Cardiovascular disease (CVD) remains the number one cause of death in the United States, claiming over 830,000 lives in 2006 (last full data set available).1 This represents 26% of the more than 2.4 million people who died that year (Figure 10-1). The economic impact and prevalence of this disease are extensive. Estimated direct and indirect costs for 2010 were $485.6 billion for the 81.1 million American adults that had CVD. The prevalence of two or more risk factors for adults 18 years of age or older varies with ethnicity, education, income, and employment status. Data from the 2003 Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System indicate that these factors were highest among blacks (48.7%) and American Indians/Alaska Natives (46.7%) and lowest among Asians (25.9%). Multiple risk factors ranged from 25.9% for college graduates to 52.5% for those with less than a high school diploma (or equivalent). Individuals with household income of $10,000 or less had the highest prevalence (52.5%), whereas those with $50,000 or more had the lowest prevalence (28.8%). Adults who were unable to work had the highest prevalence (69.3%), followed by retired persons (45.1%), unemployed adults (43.4%), homemakers (34.3%), and employed persons (34.0%).



Coronary heart disease (CHD), disease specifically of the heart and its vascular supply, is responsible for 51% of all deaths caused by CVD (Figure 10-2).1 This represents 1 of every 6 deaths in the United States in 2006. Approximately every 25 seconds an American undergoes a coronary event, and about every minute someone dies of a cardiac event. For 2010, an estimated 785,000 Americans had a new heart attack (myocardial infarction [MI]) and 470,000 had recurrent attacks. Besides attempts to alter the lifestyle of a person who is at risk for heart disease to decrease the risk factors, direct intervention is commonly used to manage heart disease. In 2006, an estimated 1,313,000 percutaneous coronary interventions (PCIs, previously referred to as angioplasties) were performed. The most common PCI procedure requires inserting a tube into a coronary vessel and inflating a balloon on the end of the tube to open up a blockage in the vessel to restore normal blood flow. Nearly half a million coronary artery bypass procedures were performed, 418,000 pacemaker procedures were completed, and 2163 heart transplantations were performed in 2006.1



Chronic obstructive pulmonary disease (COPD) comprises a group of lung diseases that are characterized by obstruction of airflow through the bronchial system and in some cases destruction of lung parenchyma. Emphysema and chronic bronchitis are the two most common COPD conditions and are often found together in the same patient. Asthma is not included in this definition of COPD.


In 2008 (last full data set available), 12.1 million people in the United States aged 18 or over had a diagnosis of COPD.2 COPD is the fourth leading cause of death in the United States, and for the last 7 years more women than men died of COPD. As in CVD, gender, race, and age affect the population in which COPD develops. In 2008 the highest percentage of individuals with chronic bronchitis consisted of non-Hispanic white females from the South, ranging from 45 to 64 years of age. The greatest percentage of individuals with emphysema also consisted of non-Hispanic white females from the South, but over the age of 65. In 2010, the projected annual cost of COPD to the nation was $49.9 billion. This included $29.5 billion in direct health care costs, $8 billion in indirect morbidity costs, and $12.4 billion in indirect mortality costs.


As the profession is moving toward direct patient access, PTs must have a thorough understanding of the normal anatomy and physiology of the cardiac and pulmonary systems. With this knowledge, the therapist can evaluate these systems, determine if the patient is appropriate to treat, and develop optimal rehabilitation programs.



Cardiovascular System


Heart


The heart is positioned left of center in the chest cavity (mediastinum), with the base located superiorly and the apex inferiorly and left of center. A fibrous tissue known as the pericardial sac surrounds the heart. The major portion of the heart is made up of muscle tissue referred to as the myocardium. This tissue is cross-striated with layers of muscle fibers arranged in multiple directions.3


The heart has two pairs of matched chambers. The two atria are thin-walled chambers, whereas the two ventricles have much thicker muscular walls (Figure 10-3).4 These chambers are separated by valves that direct the blood through the chambers in a specific pattern.



The right atrium receives venous blood from the body through the superior and inferior venae cavae. With atrial contraction (atrial systole) the blood then passes through the tricuspid valve into the right ventricle (Figure 10-4, A).4 The left atrium receives oxygenated blood through the pulmonary veins coming from the lungs. During atrial systole, this oxygenated blood passes through the bicuspid (mitral) valve into the left ventricle (Figure 10-4, B).4



Once the right and left ventricles have received blood from their respective atria, ventricular contraction (ventricular systole) occurs. This contraction results in an increase in pressure in the ventricular chambers, which causes the tricuspid and bicuspid valves to close tightly and prevents blood from passing back into the atria. As ventricular contraction continues, venous blood leaves the right ventricle through the pulmonic or semilunar valve and flows into the lungs to be reoxygenated. Oxygenated blood leaves the left ventricle through the aortic valve into the aorta to be transported to the body through the systemic circulation.


It is significant that the ventricles have thicker muscular walls than the atria. This greater muscle mass, especially in the left ventricle, must provide enough force to overcome the resistance to flow that blood encounters as it moves through the peripheral arteries.5



Conduction


The myocardium contains special types of tissue responsible for conducting the electrical impulse that causes the myocardium to contract in a synchronized pattern. The synchronized depolarization and repolarization of cardiac muscle result in efficient movement of blood through the chambers of the heart and through the coronary and peripheral vessels.


The specialized tissues are called nodal and Purkinje fibers (Figure 10-5).6 The sinoatrial (SA) node initiates the impulse (sinus rhythm) and is referred to as the pacemaker of the heart. Once a signal is initiated by the SA node, it travels quickly through the walls of the atria on special tracts to the atrioventricular (AV) node. The impulse also travels to the muscle fibers of the atria and causes them to contract. The AV node transports the signal to the bundle of His, which is where the Purkinje fibers start to spread out into the muscle fibers of the ventricles. For every heartbeat or contraction, the depolarization signal that causes the myocardium to contract must travel through this conduction system of the heart.



Both the SA and AV nodes receive autonomic nerve fibers via the sympathetic and parasympathetic systems. These nerve fibers release special neurotransmitters that influence the rate of contraction and myocardial contractility. The ability to influence the heart’s rate and contractility is extremely important because this mechanism allows the central nervous system to tell the heart how to respond to increases in demand, such as those made during exercise.5



Coronary Arteries


The myocardium receives its blood supply from two major vessels: the right and left coronary arteries (Figure 10-6).7 These arteries arise from the ascending aorta, which is the major artery leaving the left ventricle and carrying blood to the body (see Figure 10-3). In general, the right and left coronary vessels supply the right and left sides of the heart, respectively; however, this arrangement can vary a great deal among individuals. If something occurs that causes blockage of a coronary vessel, it is important to determine exactly how that blockage alters blood flow to the individual’s myocardium. A blockage that prevents oxygen supply to the heart, causing permanent damage to the heart cells, is known as a heart attack (myocardial infarction or MI).




Peripheral Circulation


The blood vessels that make up the peripheral circulation are arteries, capillaries, and veins, and disorders in these vessels can result in cardiovascular and pulmonary dysfunction. PTs and PTAs work with a variety of patients who have disabilities caused by pathologic changes in the peripheral circulation.


The arteries, of which the aorta has the largest diameter, and the arterioles have elastic fibers and smooth muscle in their walls. If the smooth muscle contracts, the diameter of the vessel is decreased, which causes an increase in the resistance to blood flow through the vessels. Arterioles are often referred to as “resistance vessels.” Changes in resistance to blood flow in the peripheral circulation directly affect how hard the heart has to work to pump blood through the body. A disease called arteriosclerosis, which is often referred to as “hardening of the arteries,” causes plaque to build up on the inner wall and decreases the elasticity of the vessel, with subsequently higher resistance to blood flow.


Capillaries are the smallest vessels in the peripheral circulation. They connect arteries to veins and can be so small that they allow only one red blood cell to pass through at a time. Their walls are only one cell thick, which permits efficient exchange of oxygen and carbon dioxide. Nutrients and waste products also pass through the wall. Capillaries are often referred to as “exchange vessels.”


The veins, which return blood to the heart from the body, have much less elastic fiber and smooth muscle in their walls. The larger veins can act as a blood reservoir and are often called “capacitance vessels.”



Pulmonary System


Respiration


Respiration is the process of exchanging oxygen and carbon dioxide between the air we breathe and blood cells that pass through the lungs. Ventilation is the process of exchanging air between the atmosphere and the lungs through inspiration and expiration.8 The mechanics of inspiration and expiration depend on many factors, including the structure of the lungs, chest, and muscles. Inspiration occurs when the muscles of ventilation, the most important being the diaphragm, contract to cause an increase in the space within the thoracic cavity. This expansion causes air pressure to drop inside the lungs, which causes air to move into the lungs. Expiration is the reverse of this process.


If the body needs increased amounts of oxygen, such as during exercise, the amount of air that must flow into and out of the lungs must markedly increase. When this situation occurs, the muscles of ventilation must work extensively. When disease affects the lungs, the results can be the same. In this case, however, the body is not requiring more oxygen. The ability of air to move normally into and out of the lungs is compromised because of blockage of the tubes that conduct the air. This obstruction results in high resistance to airflow and increased work for the muscles of ventilation.9



Conducting Airways and Lungs


Conducting airways are the passageways and tubes that transport air into and out of the lungs. The upper conducting airway includes the nose, pharynx, and larynx. This component of the air transport system cleans and humidifies the air and terminates at the beginning of the trachea. The lower conducting airway is made up of the trachea and bronchiole system (Figure 10-7).9 The bronchiole system consists of tubes branching from the main bronchus out to the terminal bronchioles. It is here that the conduction system ends and air enters into the alveolus, where gas exchange takes place. The alveoli are surrounded by capillaries that contain deoxygenated blood coming from the right ventricle of the heart. It is at this junction that oxygen and carbon dioxide are exchanged, with the reoxygenated blood returning to the left atrium. The lungs are compartmentalized into a system of lobes, which are present because of the structure of the bronchial airway system (Figure 10-7). A special membrane, the pleura, covers the outer surface of the lungs and the inner surface of the chest wall. The pleura is extremely important to the process of ventilation and maintenance of the continuity of the lungs.3




Cardiovascular and Pulmonary System Integration


The importance of interaction between the cardiovascular and pulmonary systems is clear: when disease affects one system, eventually the other system will also be affected. For example, if arteriosclerosis develops in the coronary vessels, the amount of oxygen going to the heart muscle will be decreased. With time the heart muscle begins to fail and will not pump blood to the lungs and body efficiently. Eventually, this insufficiency results in an increase in blood volume and pressure in the lungs, which in turn causes a decrease in lung efficiency and, finally, permanent damage.


The degree of success that PTs or PTAs have in establishing appropriate examination and intervention procedures for individuals with cardiovascular or pulmonary disease depends in part on how well they understand how each system functions and interacts. The following section briefly describes common cardiovascular and lung diseases that are treated with physical therapy.



Common Conditions


Cardiovascular Diseases


Two major categories of disease processes influence the myocardium: ischemic conditions and cardiac muscle dysfunction.10



Ischemic Conditions


Ischemia occurs in the presence of insufficient blood flow and results in inadequate oxygenation of tissues because of a blocked blood vessel. In CVD, arteriosclerosis affects the coronary vessels and is commonly called coronary heart disease. Angina is the condition in which chest pain occurs from ischemia of the heart muscle.


The cause of arteriosclerosis, which can affect all vessels of the body, is not completely understood. It is clear, however, that the severity of the arteriosclerotic process can be influenced by many risk factors (Box 10-1).11 Some of these factors cannot be changed, such as having a family history of CHD. However, most of these risk factors can be modified or eliminated completely by changes in behavior. PTs and PTAs promote a healthy lifestyle and help patients with cardiac dysfunction to alter their behavior as they progress through the rehabilitation process.




Cardiac Muscle Dysfunction


Cardiac muscle dysfunction refers to various pathologic conditions associated with heart failure.10 Heart failure occurs when a disease process or congenital defect either directly or indirectly causes a decrease in the pumping capability of the heart muscle. These disease processes can occur either acutely or gradually. An example of an acute change in the heart’s pumping capability is the occurrence of an MI (heart attack). In this case one of the coronary arteries suddenly becomes blocked by an embolus (clot). When embolism occurs, blood flow to heart muscle beyond the embolus stops, and the part of the heart muscle no longer receiving blood dies. If this embolus causes an interruption in blood flow to a large amount of heart muscle, death can result.


If an individual survives a heart attack, other symptoms may develop that further complicate the condition. One of the major complications after infarction is an abnormal rhythm in the sequence of heart muscle contraction (abnormal conduction). This problem makes the heart contraction inefficient. If the left ventricle is seriously damaged from the infarct, it may not contract strongly enough to move the blood through the body appropriately. This deficiency can cause the blood to back up into the lungs, or it may seriously limit function, such as the heart’s ability to respond to an increase in physical activity.


When the heart muscle is compromised to the point that it cannot move blood volume effectively, congestive heart failure (CHF) will develop. This disorder can occur acutely or chronically. When CHF is present, the ventricles are not adequately pumping the appropriate volume from their chambers. When the right ventricle is not contracting efficiently, blood volume backs into the venous system and fluid collects in the liver, abdominal cavity, and legs. If the left ventricle does not contract appropriately, an abnormal amount of blood volume remains in the lungs, which results in fluid collection. The right ventricle then has to work harder because it must try to push blood into the lungs against increased resistance. This increased workload eventually leads to compromised function of the right ventricle (see Figure 10-4, A).


A person with CHF has many clinical problems. If fluid collects in the lungs, breathing becomes more difficult and the blood is not oxygenated appropriately. If fluid has collected in the legs, walking becomes more difficult. Because of increasing difficulty in performing activities, the patient would have to expend more energy to accomplish simple tasks. With increased energy expenditure, the heart would have to work harder to support simple functional activities. To develop an appropriate treatment program for a patient with problems of this type, a PT must have a thorough understanding of how these disease processes compromise function.



Lung Diseases


Diseases of the lung are generally classified as being obstructive or restrictive. If pathologic changes in the lung cause an abnormality in airflow through the bronchial tubes, the process is defined as obstructive lung disease, whereas if pathologic changes cause the volume of air in the lungs to be reduced, the process is defined as restrictive lung disease.10 How lung diseases are classified is a controversial subject. What is most important is that the common diseases that change lung function eventually demonstrate both obstructive and restrictive characteristics.12



Chronic Obstructive Pulmonary Disease


COPD is a group of disorders that produce certain specific physical symptoms. These symptoms include chronic productive cough, excessive mucus production, changes in the sound produced when air passes through the bronchial tubes, and shortness of breath (dyspnea). The specific disorders that can produce these changes include chronic bronchitis (inflammation of the bronchi), emphysema (trapping of air in the alveoli), and peripheral airway disease (collapse of terminal bronchioles). Other disorders sometimes included in this disease group include bronchial asthma (spasmlike contraction of bronchi, resulting in air trapping) and cystic fibrosis (dysfunction of mucous glands, causing blockage of bronchi).12 Differences between these obstructive diseases include their cause, pathology (what tissues are affected and how they are changed), and management. However, all of them cause similar symptoms in varying degrees.


The signs and symptoms that develop as COPD progresses include bronchial wall abnormalities that cause a decrease in lumen size and alveolar destruction. This process results in trapping of air in the lungs, which causes the lungs to become hyperinflated, and in a decrease in gas exchange in the alveoli, which results in hypoxemia (below-normal oxygenation of blood). Hypoxemia occurs when the lungs cannot adequately supply oxygen to or retrieve carbon dioxide from the red blood cells as the cells pass by the alveoli.


As resistance to airflow increases because of the decreasing lumen size of the bronchioles, the thorax enlarges as a result of air trapping. This enlargement of the thorax causes the respiratory muscles to work harder. With time, the effectiveness of the respiratory muscles decreases. With chronic hypoxemia, changes begin to occur in the function of the heart, in blood pressure, and in the thickness of the blood. All these changes can lead to respiratory failure.10,12



Restrictive Lung Diseases


Restrictive lung diseases cause a decrease in the ability of the lungs to expand, which results in a decrease in the volume of air that can move into and out of the lungs. This disease process that affects lung tissue directly is most commonly of idiopathic, or unknown, origin. Known causes include chronic inhalation of air pollutants such as coal dust, silicon, or asbestos. Infections such as pneumonia, cancer of the lung, and changes in heart function (causing chronic fluid collection in the lungs) can also result in restrictive changes. Diseases or trauma to the nerve supply to the muscles of ventilation or disease of the muscles themselves can also result in decreased movement of the chest wall. Thus many disease groups and structural changes in the chest wall can cause restrictive changes.


The signs and symptoms that develop as restrictive disease progresses include some of the same changes seen in COPD, such as shortness of breath and chronic cough. In the case of restrictive lung disease, however, the cough is nonproductive (does not bring mucus out of the lungs). Other changes include tachypnea, or an increase in the rate of breathing, which results in a marked increase in the amount of energy expended on breathing. This increased energy cost can be so severe that it results in weight loss and an emaciated appearance. Patients with restrictive lung disease are also subject to the problems associated with hypoxemia.10,12



Principles of Examination


The examination performed by PTs and PTAs is an inclusive process that involves not only the patient, but also the family and other caregivers who are participating in the overall care of the patient. It includes a review of the patient’s past medical and social history, review of the body systems, and tests and measures to gather data about the patient’s condition. Areas reviewed include not only physical parameters, but also functional, psychological, social, and employment conditions. The tests and measures that are selected to examine a patient/client depend on various parameters, including the age of the patient/client; severity of the problem; stage of recovery (acute, subacute, chronic); phase of rehabilitation (early, intermediate, late, return to activity); and home, community, and work status.13 Table 10-1 describes tests and measures commonly performed in the examination of patients with cardiovascular and pulmonary conditions.13



Table 10-1


Description of Common Tests and Measures for Patients with Cardiovascular and Pulmonary Conditions































Function or Characteristic Description
Home, work, and community (job, play, school) Analysis of the home and work environments to determine the level of functional capacity needed to perform safely within these environments. Examination of the patient’s capacity to function at an appropriate level of social interaction with various populations (e.g., family, peers, strangers).
Ergonomics and body mechanics Determination of the dynamic capabilities required of the patient to safely perform within various environments (e.g., home, work, school, leisure).
Aerobic capacity and endurance Assessment of cardiovascular and pulmonary performance during controlled exercise and functional activities. Can include measuring oxygen consumption, heart and respiratory rates, blood pressure, dyspnea, and blood gases; electrocardiogram; and heart and lung auscultation.
Ventilation and respiration Assessment of pulmonary function, arterial blood gases, airway clearance efficiency, and perceived exertion and dyspnea during and after exercise; measurements of strength and endurance of muscles of ventilation and of chest wall mobility and expansion.
Anthropometric characteristics Determination of body fat composition.
Muscle strength and endurance Assessment of functional muscle strength and endurance as they relate to exercise protocols.
Posture Assessment of posture abnormalities and their effect on energy cost during movement.
Range of motion Assessment of limitations in joint range of motion and impact on energy cost during movement.

Data from American Physical Therapy Association (APTA): Guide to physical therapist practice, revised ed 2, Alexandria, Va, 2003, APTA.

Stay updated, free articles. Join our Telegram channel

Mar 13, 2017 | Posted by in PHYSICAL MEDICINE & REHABILITATION | Comments Off on Physical Therapy in Cardiovascular and Pulmonary Conditions

Full access? Get Clinical Tree

Get Clinical Tree app for offline access